e-learning
resources
ERJ
2002
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Fluticasone propionate attenuates platelet-activating factor-induced gas exchange defects in mild asthma
Acuna A.A., Gabrijelcic J., Uribe E.M., Rabinovich R., Roca J., Barbera J.A., Chung K.F., Rodriguez-Roisin R.
Source:
Eur Respir J 2002; 19: 872-878
Journal Issue:
May
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Acuna A.A., Gabrijelcic J., Uribe E.M., Rabinovich R., Roca J., Barbera J.A., Chung K.F., Rodriguez-Roisin R.. Fluticasone propionate attenuates platelet-activating factor-induced gas exchange defects in mild asthma. Eur Respir J 2002; 19: 872-878
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Formoterol protects against platelet-activating factor-induced effects in asthma
Source: Eur Respir J 2004; 23: 71-75
Year: 2004
Effects of salmeterol/fluticasone propionate (SFC) on airway inflammation in induced sputum in COPD
Source: Annual Congress 2005 - Effects of anti-inflammatory drugs on COPD
Year: 2005
Inhaled corticosteroids: effects on the airway vasculature in bronchial asthma
Source: Eur Respir J 2006; 27: 172-187
Year: 2006
Inhaled corticosteroids and growth of airway function in asthmatic children
Source: Eur Respir J 2004; 23: 861-868
Year: 2004
Dose reduction of inhaled corticosteroids under concomitant medication with montelukast in patients with asthma
Source: Eur Respir J 2002; 20: 1080-1087
Year: 2002
Effects of roflumilast on exhaled NO, airway hyperresponsiveness, and inflammatory markers in patients with asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 670s
Year: 2006
Montelukast versus fluticasone: effects on lung function, airway responsiveness and inflammation in moderate asthma
Source: Eur Respir J 2002; 20: 853-858
Year: 2002
Stable COPD: predicting benefit from high-dose inhaled corticosteroid treatment
Source: Eur Respir J 2006; 27: 964-971
Year: 2006
Benralizumab attenuates airway eosinophilopoietic processes in prednisone-dependent asthma
Source: International Congress 2017 – Monitoring novel biomarkers in asthma
Year: 2017
Neutrophil airway influx by platelet-activating factor in asthma: role of adhesion molecules and LTB4 expression
Source: Eur Respir J 2003; 22: 290-297
Year: 2003
Pulmonary gas exchange responses to histamine and methacholine challenges in mild asthma
Source: Eur Respir J 2001; 17: 609-614
Year: 2001
Effects of fluticasone and ciclesonide on pulmonary function and airway inflammation in stable mild asthmatics
Source: Annual Congress 2009 - Aspects of clinical asthma
Year: 2009
Markers of airway inflammation and airway hyperresponsiveness in patients with well-controlled asthma
Source: Eur Respir J 2001; 18: 444-450
Year: 2001
Evaluation of the effect of inhaled ciclesonide on inflammatory and allergic markers and pulmonary function in bronchial asthma
Source: Annual Congress 2008 - Improving asthma and anti-allergic therapy
Year: 2008
Montelukast inhibits bronchoconstriction and gas exchange defects induced by leukotriene D
4
challenge in asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 308s
Year: 2002
Salbutamol but not ipratropium fully abolish leukotriene D
4
-induced gas exchange abnormalities and induced sputum eosinophilia in asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 412s
Year: 2003
Influence of inhaled corticosteroids on airway epithelial cell mediator release in wheezing children
Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children
Year: 2008
Effect of the addition of montelukast on airway inflammation and remodeling in symptomatic asthma
Source: International Congress 2017 – Asthma: mechanisms and treatment
Year: 2017
Effects of N-acetylcysteine on airway inflammation, airway hyperresponsiveness and abnormal lung function in chronic ozone-induced COPD model
Source: Annual Congress 2012 - Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD
Year: 2012
Inhaled doxycycline reduces allergen-induced airway inflammation, hyperresponsiveness and remodelling in mice
Source: Annual Congress 2005 - Inflammation and remodelling in allergy and asthma
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept